Westerterp-Plantenga M S, Kovacs E M R
Department of Human Biology, University of Maastricht, Maastricht, The Netherlands.
Int J Obes Relat Metab Disord. 2002 Jun;26(6):870-2. doi: 10.1038/sj.ijo.0801979.
Assessment of the effects of 2 weeks of daily administration of HCA on energy intake and satiety in overweight men and women.
A 6-week randomized placebo-controlled single-blinded cross-over trial.
consumed three times daily for 2 weeks 100 ml tomato juice (placebo) and, separated by a 2 week wash-out period, 100 ml tomato juice with 300 mg HCA.Subjects: Twelve males and 12 females (body mass index 27.5+/-2.0 kg/m(2); age 37+/-10 y).
After 2 weeks, 24 h energy intake (EI), appetite profile, hedonics, mood and possible change in dietary restraint were assessed in the laboratory restaurant. Prevention of degradation and bio-availability was documented.
Twenty-four-hour EI was decreased by 15-30% (P<0.05) with HCA treatment compared to placebo, without changes in the appetite profile, dietary restraint, mood, taste perception and hedonics, while body weight tended to decrease (P=0.1).
HCA treatment reduced 24 h EI in humans while satiety was sustained.
评估连续两周每日服用HCA对超重男性和女性能量摄入及饱腹感的影响。
一项为期6周的随机安慰剂对照单盲交叉试验。
连续两周每日三次饮用100毫升番茄汁(安慰剂),并在为期2周的洗脱期后,饮用含300毫克HCA的100毫升番茄汁。受试者:12名男性和12名女性(体重指数27.5±2.0千克/平方米;年龄37±10岁)。
两周后,在实验室餐厅评估24小时能量摄入(EI)、食欲状况、享乐感受、情绪以及饮食限制可能发生的变化。记录防止降解和生物利用度的情况。
与安慰剂相比,HCA治疗使24小时EI降低了15% - 30%(P<0.05),食欲状况、饮食限制、情绪、味觉感知和享乐感受均无变化,而体重有下降趋势(P = 0.1)。
HCA治疗可降低人体24小时EI,同时维持饱腹感。